How a Remarkable Trial on Bedrest During the Korean War Led to Evidence‑based Medicine

Why It Matters

The trial demonstrated that entrenched clinical practices can be overturned by well‑designed research, paving the way for evidence‑based medicine—a framework that improves patient outcomes and reduces wasteful care. Its legacy influences how modern clinicians evaluate treatments and allocate resources.

Key Takeaways

• Chalmers' 1955 RCT proved bed rest unnecessary for hepatitis patients
• Sackett used the trial to challenge senior doctors' eminence‑based advice
• The study sparked Sackett's push for research‑driven clinical training
• Evidence‑based medicine now ranks with sanitation, antibiotics, vaccines

Pulse Analysis

The Korean War created a unique medical laboratory in Kyoto, where an outbreak of infectious hepatitis threatened both soldiers’ health and the army’s logistical capacity. Dr. Thomas Chalmers, recognizing the cost of two‑month hospital stays, designed one of the earliest randomized controlled trials. By assigning comparable patients to strict bed rest versus "ad lib" activity, he showed that early mobilization did not delay recovery, a finding that cut hospital time and challenged a long‑standing therapeutic norm.

Decades later, a young David Sackett, then a medical student at Chicago’s Cook County Hospital, stumbled upon Chalmers’ report while searching for evidence to support a restless teenager’s request to leave bed. The trial’s clear results convinced Sackett to defy senior physicians and let the patient move, confirming the study’s conclusions. This personal victory ignited Sackett’s lifelong crusade against "eminence‑based" medicine, leading him to McMaster University where he helped formalize the teaching of problem‑oriented, evidence‑driven care. The term "evidence‑based medicine" entered the literature in 1991, and within a decade it became a cornerstone of curricula worldwide.

Today, evidence‑based medicine is taken for granted, yet the bed‑rest trial reminds clinicians that many accepted practices remain untested. Ongoing challenges include heterogeneous study quality, publication bias, and the need to translate findings into real‑world settings. As health systems grapple with rising costs and information overload, the discipline’s core principle—decisions grounded in rigorous data—remains essential for delivering effective, efficient care. Continuous appraisal of new evidence ensures that medicine evolves, avoiding the pitfalls of outdated dogma.